Nath Bio-Genes (India) Ltd (NATHBIOGEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "172.65",
    "chg": 5.55,
    "chgp": "3.32%",
    "dir": 1,
    "prev_price": "167.10",
    "mcapval": "319.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "India SENSEX",
    "isin": "INE448G01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "44.27 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3985456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_mojoScore_3985456.png",
        "date": "2026-05-11 10:10:28",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nath Bio-Genes Falls 9.61% Amid Profit Wipeout and Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-961-amid-profit-wipeout-and-mixed-financial-signals-3983506",
        "imagepath": "",
        "date": "2026-05-09 16:08:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 5:</strong> Profit wipeout amid tax anomaly raises red flags</p>\n                    <p><strong>May 6:</strong> Flat quarterly performance reported with mixed financial trends</p>\n                    <p><strong>May 8:</strong> Week closes at Rs.171.15, down 9.61%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.189.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.171.15</div><div class=\"stat-change negative\">-9.61%</div></div>\n                    <div class=\"stat-item\"><div cl..."
      },
      {
        "title": "Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-reports-flat-quarterly-performance-amid-mixed-financial-trends-3977731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_fintrenddot_3977731.png",
        "date": "2026-05-06 11:00:16",
        "description": "Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector."
      },
      {
        "title": "Are Nath Bio-Genes (India) Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nath-bio-genes-india-ltd-latest-results-good-or-bad-3976442",
        "imagepath": "",
        "date": "2026-05-05 19:16:48",
        "description": "Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. \n\nIn terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss.\n\nThe company’s financial performa..."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3969968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3969968.png",
        "date": "2026-04-30 10:10:38",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3952845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3952845.png",
        "date": "2026-04-19 10:10:37",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "A 10.53% Single-Day Surge Takes Nath Bio-Genes (India) Ltd to Its Upper Circuit Limit of Rs 183.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-surges-to-upper-circuit-on-robust-buying-momentum-3944974",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_stocks_hitting_upper_circuit_3944974.png",
        "date": "2026-04-13 15:00:08",
        "description": "At Rs 183.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nath Bio-Genes (India) Ltd locked at its upper circuit of 10.53% on 13 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Nath Bio-Genes Falls 7.43%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-743-3-key-factors-driving-the-weekly-decline-3921993",
        "imagepath": "",
        "date": "2026-03-28 15:02:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock hits 52-week low at Rs.135 amid broad market weakness</p>\n                    <p><strong>24 Mar:</strong> Downgrade to Strong Sell by MarketsMOJO due to worsening fundamentals and technicals</p>\n                    <p><strong>27 Mar:</strong> New 52-week low at Rs.129.15 as downtrend continues</p>\n                    <p><strong>27 Mar Close:</strong> Week ends at Rs.129.65, down 7.43%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.140.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div..."
      },
      {
        "title": "Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3909402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_mojoScore_3909402.png",
        "date": "2026-03-24 08:31:18",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, weak long-term fundamentals, and a cautious valuation outlook, signalling heightened risks for investors amid ongoing market pressures."
      }
    ],
    "total": 15,
    "sid": "628630",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "28-May-2026",
      "details": "Annual Secretarial Compliance Report for 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "NBIL Concall",
      "datetime": "11-May-2026",
      "details": "Audio Transcript of Concall held on 05th May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "11-May-2026",
      "details": "Earning Call Transcript held on 05th May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes (India) Ltd is Rated Sell

2026-05-11 10:10:28

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Nath Bio-Genes Falls 9.61% Amid Profit Wipeout and Mixed Financial Signals

2026-05-09 16:08:08

Key Events This Week May 5: Profit wipeout amid tax anomaly raises red flags May 6: Flat quarterly performance reported with mixed financial trends May 8: Week closes at Rs.171.15, down 9.61% Week OpenRs.189.35 Week CloseRs.171.15-9.61% <div cl...

Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends

2026-05-06 11:00:16

Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector.

Are Nath Bio-Genes (India) Ltd latest results good or bad?

2026-05-05 19:16:48

Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. In terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss. The company’s financial performa...

Nath Bio-Genes (India) Ltd is Rated Sell

2026-04-30 10:10:38

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Nath Bio-Genes (India) Ltd is Rated Sell

2026-04-19 10:10:37

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

A 10.53% Single-Day Surge Takes Nath Bio-Genes (India) Ltd to Its Upper Circuit Limit of Rs 183.52

2026-04-13 15:00:08

At Rs 183.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nath Bio-Genes (India) Ltd locked at its upper circuit of 10.53% on 13 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Nath Bio-Genes Falls 7.43%: 3 Key Factors Driving the Weekly Decline

2026-03-28 15:02:17

Key Events This Week 23 Mar: Stock hits 52-week low at Rs.135 amid broad market weakness 24 Mar: Downgrade to Strong Sell by MarketsMOJO due to worsening fundamentals and technicals 27 Mar: New 52-week low at Rs.129.15 as downtrend continues 27 Mar Close: Week ends at Rs.129.65, down 7.43% Week OpenRs.140.05 Week Close</div...

Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-03-24 08:31:18

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, weak long-term fundamentals, and a cautious valuation outlook, signalling heightened risks for investors amid ongoing market pressures.

View All News